GONITRO Drug Patent Profile
✉ Email this page to a colleague
When do Gonitro patents expire, and when can generic versions of Gonitro launch?
Gonitro is a drug marketed by Pohl Boskamp and is included in one NDA. There is one patent protecting this drug.
This drug has thirteen patent family members in six countries.
The generic ingredient in GONITRO is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gonitro
A generic version of GONITRO was approved as nitroglycerin by AM REGENT on May 24th, 1988.
Summary for GONITRO
| International Patents: | 13 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 35 |
| Patent Applications: | 1,272 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for GONITRO |
| What excipients (inactive ingredients) are in GONITRO? | GONITRO excipients list |
| DailyMed Link: | GONITRO at DailyMed |
US Patents and Regulatory Information for GONITRO
GONITRO is protected by one US patents.
Patents protecting GONITRO
Stabilized granules containing glyceryl trinitrate
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pohl Boskamp | GONITRO | nitroglycerin | POWDER;SUBLINGUAL | 208424-001 | Jun 8, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for GONITRO
See the table below for patents covering GONITRO around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Canada | 2827716 | GRANULES STABILISES CONTENANT DU TRINITRATE DE GLYCERYLE (STABILIZED GRANULES CONTAINING GLYCERYL TRINITRATE) | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2012113563 | ⤷ Try a Trial | |
| European Patent Office | 3354259 | GRANULES STABILISÉES CONTENANT DU TRINITRATE DE GLYCÉRYL (STABILIZED GRANULES CONTAINING GLYCERYL TRINITRATE) | ⤷ Try a Trial |
| European Patent Office | 2678006 | CONDITIONNEMENT DE PRÉPARATIONS PHARMACEUTIQUES SOLIDES CONTENANT LA SUBSTANCE ACTIVE TRINITRATE DE GLYCÉRYLE (PACKAGING OF SOLID PHARMACEUTICAL PREPARATIONS CONTAINING THE ACTIVE SUBSTANCE GLYCERYL TRINITRATE) | ⤷ Try a Trial |
| Canada | 2827714 | CONDITIONNEMENT DE PREPARATIONS PHARMACEUTIQUES SOLIDES CONTENANT LA SUBSTANCE ACTIVE TRINITRATE DE GLYCERYLE (PACKAGING OF SOLID PHARMACEUTICAL PREPARATIONS CONTAINING THE ACTIVE SUBSTANCE GLYCERYL TRINITRATE) | ⤷ Try a Trial |
| Australia | 2012219925 | Packaging of solid pharmaceutical preparations containing the active substance glyceryl trinitrate | ⤷ Try a Trial |
| Spain | 2565632 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2023 - 2024
NCE-1 Patent Challenge Dates 2023 - 2024
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2023, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
